Announced Wed, 22 Jul · 16:18 IST
Board meeting on July 29, 2026 to consider Q1FY27 results
Results View source PDF
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.7%1-day move
₹219.10
prior close
₹217.99
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.3+0.1-0.2+0.7+4.9+2.2———————
Up moveDown movePending
AI summary
Jagsonpal Pharmaceuticals has informed BSE that its Board of Directors will meet on Wednesday, July 29, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026. The trading window for dealing in company securities will remain closed until July 31, 2026. No financial figures have been disclosed in this intimation, which is filed under SEBI Listing Regulations 29(1).
Likely market impact
Routine procedural filing. Actual Q1FY27 numbers will be announced on July 29, 2026; watch for results on that date.